Simulations Plus (SLP) Tops Q2 EPS by 9c

Go back to Simulations Plus (SLP) Tops Q2 EPS by 9c

Simulations Plus Reports Record Second Quarter FY2018 Revenue

April 9, 2018 4:01 PM EDT

Board of Directors Announces Quarterly Dividend of $0.06 Per Share

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its second quarter of fiscal year 2018, the period ended February 28, 2018 (2QFY18).

2QFY18 highlights compared with 2QFY17:

Revenues were $7.4 million, up $1.7 million, or 28.9%, compared to $5.7 million in 2QFY17 57% of the increase is from DILIsym Services, acquired... More